Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study

Robert R. Recker, Louis George Ste-Marie, Bente Langdahl, Edward Czerwinski, Bernard Bonvoisin, Daiva Masanauskaite, Lucy Rowell, Dieter Felsenberg

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

In the Dosing IntraVenous Administration (DIVA) study, IV ibandronate injections (15-30 s duration) provided significantly greater gains in bone mineral density than daily oral ibandronate (P

Original languageEnglish (US)
Pages (from-to)660-665
Number of pages6
JournalBone
Volume46
Issue number3
DOIs
StatePublished - Mar 2010

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Histology

Fingerprint Dive into the research topics of 'Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study'. Together they form a unique fingerprint.

  • Cite this